Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
HCA Healthcare ( (HCA) ) just unveiled an update.
On July 25, 2025, HCA Healthcare announced its financial results for the second quarter of 2025, reporting a 6.4% increase in revenues to $18.605 billion and a 13.1% rise in net income to $1.653 billion compared to the same period in 2024. The company also declared a quarterly cash dividend of $0.72 per share, to be paid on September 30, 2025. HCA Healthcare raised its 2025 guidance, reflecting strong financial performance and operational improvements, with adjusted EBITDA increasing by 8.4% to $3.849 billion. The company repurchased 7.031 million shares of its common stock and had $5.753 billion remaining under its repurchase authorization as of June 30, 2025.
The most recent analyst rating on (HCA) stock is a Buy with a $425.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Neutral.
HCA’s strong financial performance and positive earnings call are offset by high leverage and bearish technical indicators. The company’s growth prospects are supported by strategic expansions and improved operations, but careful debt management and monitoring of technical trends are essential.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
HCA Healthcare operates in the healthcare industry, managing 191 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics across 20 states and the United Kingdom.
Average Trading Volume: 1,455,369
Technical Sentiment Signal: Buy
Current Market Cap: $82.15B
For detailed information about HCA stock, go to TipRanks’ Stock Analysis page.